Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Teva Pharmaceutical Industries ADR (TEVA)

Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase Zacks Investment Research - Thu Nov 7, 8:50AM CST

Teva Pharmaceutical Industries TEVA reported third-quarter 2024 adjusted earnings of 69 cents per share, which beat the Zacks Consensus Estimate of 65 cents. Adjusted earnings rose 15% year over year.Revenues...

NVO : 107.63 (+2.15%)
JNJ : 156.73 (-0.73%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript Motley Fool - Wed Nov 6, 10:30AM CST

TEVA earnings call for the period ending September 30, 2024.

TEVA : 17.50 (+0.40%)
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings? Zacks Investment Research - Tue Nov 5, 3:12PM CST

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies due to report their third-quarter 2024 results this week.The remaining large...

NVO : 107.63 (+2.15%)
VTRS : 13.18 (+13.52%)
TEVA : 17.50 (+0.40%)
GILD : 97.90 (+6.77%)
MRNA : 50.28 (-2.95%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse FinancialNewsMedia - Tue Sep 24, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 5.56 (-1.59%)
NTRBW : 1.5500 (+6.90%)
LLY : 797.45 (+2.71%)
NVS : 107.08 (+0.25%)
TEVA : 17.50 (+0.40%)
AMRX : 8.61 (+1.29%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse GlobeNewswire - Tue Sep 24, 7:45AM CDT

NTRB : 5.56 (-1.59%)
NTRBW : 1.5500 (+6.90%)
LLY : 797.45 (+2.71%)
NVS : 107.08 (+0.25%)
TEVA : 17.50 (+0.40%)
AMRX : 8.61 (+1.29%)
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold? Zacks Investment Research - Fri Sep 13, 3:08PM CDT

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for the industry. The stock has also outperformed the sector and the S&P 500, as...

SNY : 51.73 (+0.92%)
JNJ : 156.73 (-0.73%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Ozempic Medicare Negotiations Target Big Pharma in 2027 Quiver Quantitative, Inc. - Fri Aug 23, 4:18PM CDT

The anticipated 2027 Medicare drug negotiations are expected to impact several blockbuster drugs, with Novo Nordisk’s (NOVO) Ozempic, Pfizer’s (PFE) Ibrance and Xtandi, and GSK’s (GSK) Trelegy Ellipta...

PFE : 27.46 (+0.37%)
GSK : 36.66 (+2.12%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment PressReach - Tue Aug 6, 10:35AM CDT

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted...

ALZN : 1.5000 (+3.45%)
VNDA : 5.02 (+2.66%)
ITCI : 90.51 (+1.20%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript Motley Fool - Wed Jul 31, 11:00AM CDT

TEVA earnings call for the period ending June 30, 2024.

TEVA : 17.50 (+0.40%)
Charts, tickers, traders - iStock-884650780
Option Volatility And Earnings Report For July 29 – August 2 Barchart - Mon Jul 29, 6:00AM CDT

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

AAPL : 227.48 (+2.14%)
AMD : 149.82 (+3.25%)
AMZN : 210.05 (+1.43%)
PFE : 27.46 (+0.37%)
COIN : 255.58 (+0.50%)
META : 591.70 (+3.44%)
INTC : 26.23 (+4.71%)
XOM : 121.15 (+0.12%)
BA : 150.98 (+2.60%)
PYPL : 81.35 (-0.07%)
SBUX : 96.12 (+0.04%)
MCD : 294.66 (+0.22%)

Barchart Exclusives

1 Energy Dividend Stock That Just Hiked Its Cash Flow Forecast Barchart - 48 minutes ago
Analysts are optimistic about this dividend-paying energy company, which raised its cash flow forecast after surging LNG demand pushed it past Q3 expectations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot